Friday 9th March 2012 2 Comments |
Text too small? |
Gunns, the ASX-listed forest plantation owner, is in a trading halt as it looks for new capital after New Zealand-born billionaire Richard Chandler backed out of a cornerstone role in a A$280 million deal.
The Tasmanian-based company requested a two-day halt after it was “advised that the Richard Chandler Corporation does not intend to proceed with its participation in the proposed capital equity raising” outlined last month, it said in a statement to the ASX.
“The company is in discussions with equity investors in respect of the raising” and it will announce more information about the recapitalisation at the end of the discussions, it said.
Gunns shares last traded at 16 Australian cents apiece, valuing the company at A$140 million.
Chandler’s investment vehicle has been doing due diligence on Gunns for the last month, as it weighed up taking an A$150 million stake in the company as part of a rights issue.
That evaluation included whether social value is created, such as establishing jobs and improving sustainable environmental practices, attracting local support, imposing strong corporate governance, making appropriate financial returns and setting up conservative debt levels, Chandler said last month.
Chandler co-founded Sovereign Global Investment with his brother Christopher in 1986, primarily investing in emerging markets. In 2006, Sovereign demerged, and Richard Chandler established Orient Global, which is now known as RCC, according to the company’s website.
That vehicle is split into two arms, the Creative World Group which is a social investment group focusing on education and healthcare, and the Capital group which invests in a wide range of industries.
BusinessDesk.co.nz
December 27th Morning Report
FBU - Fletcher Building Announces Director Appointment
December 23rd Morning Report
MWE - Suspension of Trading and Delisting
EBOS welcomes finalisation of First PWA
CVT - AMENDED: Bank covenant waiver and trading update
Gentrack Annual Report 2024
December 20th Morning Report
Rua Bioscience announces launch of new products in the UK
TEM - Appointment to the Board of Directors